MoneyWorks4Me

Granules India informs about conference call

21 Jul 2020 Evaluate

Pursuant to provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Granules India has provided the details of one on one Conference Call meeting scheduled with the investors. Further details regarding the same above are enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1773.10
Dr. Reddys Labs. 1194.45
Cipla 1307.00
Lupin 1958.40
Zydus Lifesciences 1116.70
View more..